BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations

BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations

BCG vaccination protects not only against tuberculosis but also against heterologous infections. This effect differs between individuals, yet the factors responsible for this variation are unknown. BCG-induced nonspecific protection is, at least partially, mediated by innate immune reprogramming (tr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Vera P. Mourits, Valerie A. C. M. Koeken, L. Charlotte J. de Bree, Simone J. C. F. M. Moorlag, Wern Cui Chu, Xiaoli Xu, Helga Dijkstra, Heidi Lemmers, Leo A. B. Joosten, Yue Wang, Reinout van Crevel, Mihai G. Netea
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2020/5812743
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity
by: Hideki Kitaura, et al.
Published: (2018-01-01)

Muramyl Dipeptide Enhances Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption through Increased RANKL Expression in Stromal Cells
by: Masahiko Ishida, et al.
Published: (2015-01-01)

Innate Immune Recognition of Mycobacterium tuberculosis
by: Johanneke Kleinnijenhuis, et al.
Published: (2011-01-01)

The Nod2 Agonist Muramyl Dipeptide Cooperates with the TLR4 Agonist Lipopolysaccharide to Enhance IgG2b Production in Mouse B Cells
by: Sang-Hoon Lee, et al.
Published: (2019-01-01)

Application of N-Acetyl-Glucosaminil-N-Acetyl-Muramyl Dipeptide during Triple Component Anti-Helicobacter Pylori Therapy in the Period of Coronavirus Infection COVID-19
by: M. R. Konorev, et al.
Published: (2023-08-01)

Borrelia burgdorferi sensu lato inhibits CIITA transcription through pSTAT3 activation and enhanced SOCS1 and SOCS3 expression leading to limited IFN-γ production
by: Michelle A.E. Brouwer, et al.
Published: (2025-01-01)

Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in Indonesia
by: Todia P. Setiabudiawan, et al.
Published: (2025-01-01)

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
by: J Alfred Witjes, et al.
Published: (2023-01-01)

The dipeptide carnosine alleviates acute pancreatitis in an experimental model
by: Heresh Rezaei, et al.
Published: (2024-12-01)

Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids
by: Ekta Lachmandas, et al.
Published: (2016-01-01)

Recognition and Treatment of BCG Failure in Bladder Cancer
by: Andrew J. Lightfoot, et al.
Published: (2011-01-01)

Effects of Zinc Binding on the Structure and Stability of Glycylglycine Dipeptide: A Computational Study
by: Mohammad T. Baei, et al.
Published: (2012-01-01)

Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)

Is the BCG Vaccine Safe for Undernourished Individuals?
by: Larissa Lumi Watanabe Ishikawa, et al.
Published: (2012-01-01)

Spatial co-distribution of tuberculosis prevalence and low BCG vaccination coverage in Ethiopia
by: Haileab Fekadu Wolde, et al.
Published: (2024-12-01)

Infantile BCG osteomyelitis ultimately diagnosed as a result of trauma
by: Katsuhiko Tabata, MD, et al.
Published: (2025-03-01)

Oral Administration of the Adiponectin Receptor 1 Agonistic Dipeptide Tyr-Pro Prevents Hyperglycemia in Spontaneously Diabetic Torii Rats
by: Saya Nakamura, et al.
Published: (2024-12-01)

Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain
by: Hideyuki Isobe, et al.
Published: (2025-01-01)

Immune responses of cattle vaccinated by various routes with Mycobacterium bovis Bacillus Calmette-Guérin (BCG)
by: Mitchell V. Palmer, et al.
Published: (2025-01-01)

Hubungan antara Pembentukan Scar Vaksin BCG dan Kejadian Infeksi Tuberkulosis
by: Fajriah Rosandali, et al.
Published: (2016-08-01)

The Impact of Transcriptomics on the Fight against Tuberculosis: Focus on Biomarkers, BCG Vaccination, and Immunotherapy
by: Carlos Rodrigo Zárate-Bladés, et al.
Published: (2011-01-01)

Immunological Links to Nonspecific Effects of DTwP and BCG Vaccines on Infant Mortality
by: Mogens Helweg Claesson
Published: (2011-01-01)

Acute Hepatitis Induced by Intravesical BCG Therapy: A Rare but Serious Complication
by: Hakima Abid, et al.
Published: (2021-01-01)

Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency
by: Sílvia Bacalhau, et al.
Published: (2011-01-01)

Mycobacterium bovis BCG Surface Antigens Expressed under the Granuloma-Like Conditions as Potential Inducers of the Protective Immunity
by: Yingyu Chen, et al.
Published: (2019-01-01)

Synthesis and Antifungal Activity of Fmoc-Protected 1,2,4-Triazolyl-α-Amino Acids and Their Dipeptides Against <i>Aspergillus</i> Species
by: Tatevik Sargsyan, et al.
Published: (2025-01-01)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024-11-01)

Antibodies directed to antigens secreted by murine epithelioid macrophages modulate BCG-induced granulomata
by: Mario Mariano, et al.
Published: (1993-01-01)

NLS-binding deficient Kapβ2 reduces neurotoxicity via selective interaction with C9orf72-ALS/FTD dipeptide repeats
by: Kevin M. Kim, et al.
Published: (2025-01-01)

Comparative performance of tuberculin and defined-antigen cocktails for detecting bovine tuberculosis in BCG-vaccinated cattle in natural settings
by: Abebe Fromsa, et al.
Published: (2025-02-01)

Differentially Expressed Genes Study Shown Potential for BCG Stimulation in Reducing the Severity of COVID-19
by: Irandi Putra Pratomo, et al.
Published: (2022-01-01)

Novel target and cofactor repertoire for the transcriptional regulator JTY_0672 from Mycobacterium bovis BCG
by: Hui Wang, et al.
Published: (2025-01-01)

Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG)
by: Eric Gomez, et al.
Published: (2009-01-01)

Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
by: Peter Aaby, et al.
Published: (2020-02-01)

Adverse Events of the BCG (Bacillus Calmette–Guérin) and Rotavirus Vaccines in a Young Infant with Inborn Error of Immunity
by: Suleiman Al-Hammadi, et al.
Published: (2020-01-01)

Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
by: Nirajan Niroula, et al.
Published: (2025-01-01)

Antigen-Specific Tissue-Resident Memory T Cells in the Respiratory System Were Generated following Intranasal Vaccination of Mice with BCG
by: Qiongli Wu, et al.
Published: (2021-01-01)

Later-Life Mortality and Longevity in Late-18th and 19th-Century Cohorts. Where Are We Now, and Where Are We Heading?
by: Rich J. Mourits
Published: (2017-01-01)

Studying immunotherapeutic properties of the conjugate based on BCG antigens with betulonic acid in guinea pigs infected with <i>Mycobacterium scrofulaceum</i>
by: I. N. Koshkin, et al.
Published: (2024-06-01)

Immunogenicity and Protective Efficacy of a Novel Recombinant BCG Strain Overexpressing Antigens Ag85A and Ag85B
by: Chun Wang, et al.
Published: (2012-01-01)